TNFRSF13C and systemic lupus erythematosus: Together, BAFF/BAFF-R antagonism moderates plasma B cells, lowers autoreactive antibodies and immune complexes in circulation, and effectively combats systemic inflammation and tissue damage in SLE (including LN).